FDA Inspection 938356 — Zhejiang Hisoar Pharmaceutical Co. Ltd.
The FDA completed an inspection of Zhejiang Hisoar Pharmaceutical Co. Ltd. on August 13, 2015 in Taizhou. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Veterinary.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- August 13, 2015
- Fiscal Year
- 2015
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Taizhou (China)